Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTH | P32929 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13140459 | 0.92 | CTH (0.45) | CTHKMT2AALDH1A1 | |
| SCHEMBL13140460 | 0.85 | CTH (0.49) | CTHKMT2AALDH1A1 | |
| SCHEMBL13140454 | 0.85 | CTH (0.49) | CTHKMT2AALDH1A1 | |
| SCHEMBL2549787 | 0.80 | CTH (0.49) | CTHKMT2AALDH1A1MEN1 | |
| SCHEMBL6087635 | 0.80 | CTH (0.49) | CTHKMT2AALDH1A1MEN1 | |
| SCHEMBL14094120 | 0.76 | CTH (0.41) | CTHKMT2AALDH1A1 | |
| SCHEMBL16361273 | 0.74 | KMT2A (0.60) | CTHKMT2AALDH1A1MEN1 | |
| SCHEMBL8429877 | 0.73 | CTH (0.43) | CTHKMT2AALDH1A1MEN1 | |
| SCHEMBL13140455 | 0.73 | CTH (0.64) | CTHKMT2A | |
| SCHEMBL3083347 | 0.73 | CTH (0.64) | CTHKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7795286-B2 | Silane esters and amides of 2-oxothiazolidine-4-carboxylic acid, and cosmetic uses thereof | L'OREAL (FR) | 2010-09-14 | — | — | US | disclosed |
| US-20090074682-A1 | SILANE ESTERS AND AMIDES OF 2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID, AND COSMETIC USES THEREOF | L'OREAL (FR) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074682-A1 | SILANE ESTERS AND AMIDES OF 2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID, AND COSMETIC USES THEREOF | ALDH7A1, CUTA, ALDH18A1 | CTH 680/4885KMT2A 1181/4885ALDH1A1 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.